All web articles
URGENT ACTION NEEDED TO TACKLE GLOBAL DRUG-RESISTANT TB THREAT Geneva, 21 March 2014 - A new briefing paper by Médecins Sans Frontières/Doctors Without Borders (MSF) outlines why the alarming spread...
Last updated 21 March 2014
The ministry of health must act to stop drug resistance from spiralling
South Africans urge Trade Minister to finalise IP policy before elections and open up access to medicines
Activists demand rapid completion of intellectual property policy six years in the making; without internationally recognised public health safeguards policy will be health disaster.
Despite minimal concessions, US demands remain extremely dangerous to all patients’ health across the Asia-Pacific region
Last updated 21 February 2014
Since June 2012, MSF has been treating prisoners and ex prisoners with drug-resistant tuberculosis (DR-TB) in the Donetsk region of Ukraine. Paola Mermati, MSF’s Field Coordinator in Donetsk, talks...
Last updated 18 February 2014
Conakry/Brussels/Geneva, February 8, 2014 – The humanitarian medical organization Médecins Sans Frontières (MSF) Saturday launched a vaccination campaign against measles in an attempt to control...
Last updated 13 February 2014
Tuberculosis bacteria can quickly become resistant to antibiotics, so the disease must be treated with combinations of drugs carefully designed to stave off resistance. After fifty years without any...
Last updated 15 January 2014
Updated on 10 January, 2014 A week after five international staff members were taken from an MSF house in northern Syria on the evening of January 2, 2014, MSF continues to put all efforts toward securing...
Last updated 10 January 2014
Measles is highly contagious and is easily and rapidly transmitted from one person to another through coughing, sneezing and close personal contact. The risks of transmission are therefore greater...
Last updated 8 January 2014
MSF calls for scale-up of ‘viral load’ monitoring to improve HIV treatment outcomes in developing countries
Global Fund and US-government PEPFAR programme must use purchasing power to get better prices for viral load tests